Mondobiotech Aktie
WKN: A3EFB5
ISIN: CH1251125998
Land: Schweiz
Branche: Chemie, Pharma, Bio- & Medizintechnik
Sektor: Biotechnologie
Gratis: Die zehn beliebtesten Rüstungs-Aktien im Check! Info...
2,81 EUR 0,05 EUR 1,81 %
08:00:26 München
Komplette Navigation anzeigen

News und Analysen

Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission

Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission ...weiterlesen

14.11.22
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
08.11.22
Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide additional time for the parties to finalize their litigation settlement
07.11.22
Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil)
26.10.22
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. extend their stay of pending litigation to provide additional time for the parties to finalize their settlement
25.10.22
Relief Therapeutics Files Amendment No. 2 to its Form F-6 Registration Statement with the U.S. Securities and Exchange Commission
14.10.22
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
10.10.22
Relief Announces U.S. Launch of PKU GOLIKE
06.10.22
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
03.10.22
Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate
Seite: 1 | 2 | 3

Jetzt neu: